Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Hepatitis B vaccination reduces prevalence in drug users

  • Comment

Vaccination against hepatitis B is having a positive effect among drug users, according to a Health Protection Agency report based on a sample of 3,000 injectors.

In 2009 uptake of the vaccine for hepatitis B among the injecting drug users was 73% - up from 25 per cent in 1998. This has coincided with a fall in hepatitis B prevalence from 30% in 2006 to 17% in 2009.

In contrast, levels of infection with Hepatitis C, for which there is no vaccine, increased from 38% in 2000 to 47% in 2009.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs